Empowering mesenchymal stem cells for ocular degenerative disorders

Multipotent mesenchymal stem cells (MSCs) have been employed in numerous pre-clinical and clinical settings for various diseases. MSCs have been used in treating degenerative disorders pertaining to the eye, for example, age-related macular degeneration, glaucoma, retinitis pigmentosa, diabetic reti...

Full description

Bibliographic Details
Main Authors: Ding, Shirley Suet Lee, Subbiah, Suresh Kumar, Khan, Mohammed Safwan Ali, Farhana, Aisha, Mok, Pooi Ling
Format: Article
Language:English
Published: MDPI 2019
Online Access:http://psasir.upm.edu.my/id/eprint/38403/
http://psasir.upm.edu.my/id/eprint/38403/1/38403.pdf
_version_ 1848848869825183744
author Ding, Shirley Suet Lee
Subbiah, Suresh Kumar
Khan, Mohammed Safwan Ali
Farhana, Aisha
Mok, Pooi Ling
author_facet Ding, Shirley Suet Lee
Subbiah, Suresh Kumar
Khan, Mohammed Safwan Ali
Farhana, Aisha
Mok, Pooi Ling
author_sort Ding, Shirley Suet Lee
building UPM Institutional Repository
collection Online Access
description Multipotent mesenchymal stem cells (MSCs) have been employed in numerous pre-clinical and clinical settings for various diseases. MSCs have been used in treating degenerative disorders pertaining to the eye, for example, age-related macular degeneration, glaucoma, retinitis pigmentosa, diabetic retinopathy, and optic neuritis. Despite the known therapeutic role and mechanisms of MSCs, low cell precision towards the targeted area and cell survivability at tissue needing repair often resulted in a disparity in therapeutic outcomes. In this review, we will discuss the current and feasible strategy options to enhance treatment outcomes with MSC therapy. We will review the application of various types of biomaterials and advances in nanotechnology, which have been employed on MSCs to augment cellular function and differentiation for improving treatment of visual functions. In addition, several modes of gene delivery into MSCs and the types of associated therapeutic genes that are important for modulation of ocular tissue function and repair will be highlighted.
first_indexed 2025-11-15T09:41:22Z
format Article
id upm-38403
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T09:41:22Z
publishDate 2019
publisher MDPI
recordtype eprints
repository_type Digital Repository
spelling upm-384032020-05-04T16:28:51Z http://psasir.upm.edu.my/id/eprint/38403/ Empowering mesenchymal stem cells for ocular degenerative disorders Ding, Shirley Suet Lee Subbiah, Suresh Kumar Khan, Mohammed Safwan Ali Farhana, Aisha Mok, Pooi Ling Multipotent mesenchymal stem cells (MSCs) have been employed in numerous pre-clinical and clinical settings for various diseases. MSCs have been used in treating degenerative disorders pertaining to the eye, for example, age-related macular degeneration, glaucoma, retinitis pigmentosa, diabetic retinopathy, and optic neuritis. Despite the known therapeutic role and mechanisms of MSCs, low cell precision towards the targeted area and cell survivability at tissue needing repair often resulted in a disparity in therapeutic outcomes. In this review, we will discuss the current and feasible strategy options to enhance treatment outcomes with MSC therapy. We will review the application of various types of biomaterials and advances in nanotechnology, which have been employed on MSCs to augment cellular function and differentiation for improving treatment of visual functions. In addition, several modes of gene delivery into MSCs and the types of associated therapeutic genes that are important for modulation of ocular tissue function and repair will be highlighted. MDPI 2019 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/38403/1/38403.pdf Ding, Shirley Suet Lee and Subbiah, Suresh Kumar and Khan, Mohammed Safwan Ali and Farhana, Aisha and Mok, Pooi Ling (2019) Empowering mesenchymal stem cells for ocular degenerative disorders. International Journal of Molecular Sciences, 20 (7). art. no. 1784. pp. 1-13. ISSN 1661-6596; ESSN: 1422-0067 https://www.mdpi.com/1422-0067/20/7/1784 10.3390/ijms20071784
spellingShingle Ding, Shirley Suet Lee
Subbiah, Suresh Kumar
Khan, Mohammed Safwan Ali
Farhana, Aisha
Mok, Pooi Ling
Empowering mesenchymal stem cells for ocular degenerative disorders
title Empowering mesenchymal stem cells for ocular degenerative disorders
title_full Empowering mesenchymal stem cells for ocular degenerative disorders
title_fullStr Empowering mesenchymal stem cells for ocular degenerative disorders
title_full_unstemmed Empowering mesenchymal stem cells for ocular degenerative disorders
title_short Empowering mesenchymal stem cells for ocular degenerative disorders
title_sort empowering mesenchymal stem cells for ocular degenerative disorders
url http://psasir.upm.edu.my/id/eprint/38403/
http://psasir.upm.edu.my/id/eprint/38403/
http://psasir.upm.edu.my/id/eprint/38403/
http://psasir.upm.edu.my/id/eprint/38403/1/38403.pdf